venBio Global Strategic Fund III, L.P. - Mar 31, 2025 SCHEDULE 13G/A Report for Artiva Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (ARTV)

Filing Manager: venBio Global Strategic Fund III, L.P.
Reporting Manager: venBio Global Strategic Fund III, L.P.
Security: Artiva Biotherapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: ARTV
Shares outstanding: 24.5M shares
Disclosed Ownership: 1.2M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 5/15/2025, 04:44 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
venBio Global Strategic Fund III, L.P.	4.9%	1.2M	1.2M	/s/ David Pezeshki	David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner of the General Partner
VENBIO GLOBAL STRATEGIC GP III, L.P.	4.9%	1.2M	1.2M	/s/ David Pezeshki	David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner
VENBIO GLOBAL STRATEGIC GP III, LTD	4.9%	1.2M	1.2M	/s/ David Pezeshki	David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors
Adelman Robert J	4.9%	1.2M	1.2M	/s/ David Pezeshki	David Pezeshki, as attorney-in-fact
GOODMAN COREY S	4.9%	1.2M	1.2M	/s/ David Pezeshki	David Pezeshki, as attorney-in-fact